Orthopedic Devices - Southern Asia

  • Southern Asia
  • The projected revenue in the Orthopedic Devices market market in Southern Asia is expected to reach US$0.74bn in 2024.
  • This market is anticipated to show an annual growth rate (CAGR 2024-2029) of 6.42%, leading to a market volume of US$1.01bn by 2029.
  • Comparing globally, the United States is forecasted to generate the highest revenue of US$16,020.00m in 2024.
  • In Southern Asia, the orthopedic devices market is witnessing a surge in demand due to the rising prevalence of musculoskeletal disorders in the region.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in Southern Asia is experiencing significant growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Southern Asia are driving the demand for orthopedic devices. As the population in the region continues to age, there is an increasing prevalence of orthopedic conditions such as osteoarthritis and fractures. This has led to a higher demand for orthopedic devices such as joint replacement implants and fracture fixation devices. Additionally, there is a growing awareness and acceptance of advanced orthopedic technologies among patients in Southern Asia, leading to an increased adoption of innovative devices. Trends in the market are also contributing to the growth of the Orthopedic Devices market in Southern Asia. One major trend is the shift towards minimally invasive procedures. Patients in Southern Asia are increasingly opting for less invasive surgical techniques that offer faster recovery times and reduced post-operative complications. This has led to a higher demand for orthopedic devices such as arthroscopy instruments and minimally invasive implants. Another trend is the integration of digital technology in orthopedic devices. Southern Asian countries are embracing digital health solutions, which has led to the development of smart orthopedic devices that can monitor patient progress and provide real-time data to healthcare professionals. Local special circumstances in Southern Asia are also contributing to the growth of the market. The region has a large population, which provides a significant customer base for orthopedic device manufacturers. Additionally, Southern Asian countries have been investing in healthcare infrastructure and are improving access to healthcare services, which is further driving the demand for orthopedic devices. Furthermore, the rising disposable income in the region has made orthopedic treatments more affordable for a larger portion of the population, leading to increased demand for orthopedic devices. Underlying macroeconomic factors are also playing a role in the growth of the Orthopedic Devices market in Southern Asia. The region is experiencing rapid economic growth, which has resulted in an expanding middle class with higher purchasing power. This has contributed to increased healthcare spending and an increased demand for orthopedic devices. Additionally, Southern Asian countries are investing in medical tourism, attracting patients from other regions who require orthopedic treatments. This has further boosted the demand for orthopedic devices in the region. In conclusion, the Orthopedic Devices market in Southern Asia is experiencing significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing prevalence of orthopedic conditions, the shift towards minimally invasive procedures, the integration of digital technology, the large population, improved healthcare infrastructure, rising disposable income, and rapid economic growth are all contributing to the growth of the market in the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)